DRESS syndrome

Joint Bone Spine

Volumn 81, Issue 1, 2014, Pages 15-21

  Descamps, Vincent ^a   Ranger Rogez, Sylvie ^b  

^a BICHAT HOSPITAL   (France)

^b Laboratoire de virologie   (France)

Author keywords

Cytomegalovirus; DIHS; DRESS; Epstein Barr virus; HLA; Human Herpesvirus 6; Hypersensitivity; Toxic dermatitis

Indexed keywords

ALLOPURINOL; AMINOTRANSFERASE; AMOXICILLIN; FERRITIN; GLUCOCORTICOID; LACTATE DEHYDROGENASE; LIOTHYRONINE; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR; TRIACYLGLYCEROL; IMMUNOGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; BONE MARROW BIOPSY; CASE REPORT; CYTOLYTIC HEPATITIS; DRESS SYNDROME; EOSINOPHILIA; ERYTHRODERMA; FACE EDEMA; FERRITIN BLOOD LEVEL; FREE THYROXINE INDEX; GOITER; GRAVES DISEASE; HEMOPHAGOCYTIC SYNDROME; HOSPITAL ADMISSION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN TISSUE; HYPERTHYROIDISM; INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; LAOS; LIOTHYRONINE BLOOD LEVEL; LYMPHADENOPATHY; MALE; MEASLES LIKE RASH; MIDDLE AGED; MONONUCLEOSIS; NEUTROPHIL COUNT; ODYNOPHAGIA; PANCYTOPENIA; PURPURA; REVIEW; TACHYCARDIA; THROMBOCYTE COUNT; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; DRUG HYPERSENSITIVITY SYNDROME; VIROLOGY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; DRUG ERUPTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; PRESCRIPTION; SHORT SURVEY;

DRUG HYPERSENSITIVITY SYNDROME; HUMANS; MALE; MIDDLE AGED;

EID: 84893747138     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.05.002     Document Type: Short Survey

References (40)

1. Kardaun S.H., Sidoroff A., Valeyrie-Allanore L., et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist. Br J Dermatol 2007, 156:609-611.
2. Shiohara T., Iijima M., Ikezawa Z., et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007, 156:1083-1084.
3. Eshki M., Allanore L., Musette P., et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009, 145:67-72.
4. Descamps V., Ben Saïd B., Sassolas B., et al. Prise en charge du drug reaction with eosinophilia and systemic symptoms. Ann Dermatol Venereol 2010, 137:703-708. [In French].
5. Cacoub P., Musette P., Descamps V., et al. The DRESS syndrome: a literature review. Am J Med 2011, 124:588-597.
6. Mardivirin L., Valeyrie-Allanore L., Redon E.B., et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. Eur J Dermatol 2010, 20:68-73.
7. Aihara M. Pharmacogenetics of cutaneous adverse drug reactions. J Dermatol 2011, 38:246-254.
8. Hung S.I., Chung W.H., Liou L.B., et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005, 102:4134-4139.
9. Kano Y., Hirahara K., Asano Y., et al. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 2008, 88:616-618.
10. Maubec E., Wolkenstein P., Loriot M.A., et al. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology 2008, 216:200-204.
11. Yun J., Adam J., Yerly D., et al. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA. Allergy 2012, 67:1338-1346.
12. Bharadwaj M., Illing P., Theodossis A., et al. Drug sensitivity and human leucocyte antigens of the major histocompatibility complex. Annu Rev Pharmacol Toxicol 2012, 52:401-431.
13. Pompeu Y.A., Stewart J.D., Mallal S., et al. The structural basis of HLA-associated drug hypersensitivity syndromes. Immunol Rev 2012, 250:158-166.
14. Daly A.K., Donaldson P.T., Bhatnaqar P., et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009, 41:816-819.
15. Descamps V., Bouscarat F., Laglenne S., et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997, 137:605-608.
16. Descamps V., Valance A., Edlinger C., et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001, 137:301-304.
17. Suzuki Y., Inagi R., Aono T., et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998, 134:1108-1112.
18. Tohyama M., Yahata Y., Yasukawa M., et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998, 134:1113-1117.
19. Tohyama M., Hashimoto K., Yasukawa M., et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007, 157:934-940.
20. Kano Y., Hiraharas K., Sakuma K., et al. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006, 155:301-306.
21. Descamps V., Mahe E., Houhou N., et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003, 148:1032-1034.
22. Descamps V., Mardivirin L., Ranger-Rogez S. Chromosomal integration of human herpesvirus 6 DNA in anticonvulsant hypersensitivity syndrome: a unique opportunity for the understanding of their relation. Br J Dermatol 2008, 159:759.
23. Picard D., Janela B., Descamps V., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010, 2:46ra62.
24. Descamps V. DRESS or "picture of DRESS". Bone Marrow Transplant 2012, 47:317.
25. Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994, 331:1272-1285.
26. Wang F.Z., Pellett P.E. HV-6A, 6B, and 7: immunobiology and host response. Human herpesviruses: biology, therapy, and immunoprophylaxis 2007, Cambridge University Press, Cambridge, [Chapter 48]. A. Arvin, G. Campadelli-Fiume, E. Mocarski (Eds.).
27. Zerr D.M., Meier A.S., Selke S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005, 352:768-776.
28. Ward K.N. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 2005, 32:183-193.
29. Pellett P.E., Ablashi D.V., Ambros P.F., et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2012, 22:144-155.
30. Descamps V., Milpied B., Collet E., et al. Intégration HHV-6 au sein du génome cellulaire: un facteur favorisant la survenue du DRESS. Ann Dermatol Venereol 2011, 138:A90-A91.
31. Mardivirin L., Descamps V., Lacroix A., et al. Early effects of drugs responsible for DRESS on HHV-6 replication in vitro. J Clin Virol 2009, 46:300-302.
32. Saito-Katsuragi M., Asada H., Yokoi S., et al. Ampicillin-induced cutaneous eruption associated with Epstein-Barr virus reactivation. J Am Acad Dermatol 2005, 52:S127-S128.
33. Boccara O., Valeyrie-Allanore L., Crickx B., et al. Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). Eur J Dermatol 2006, 16:666-668.
34. Aihara Y., Ito S.I., Kobayashi Y., et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003, 149:165-169.
35. Minarovits J. Epigenotypes of latent herpesvirus genomes. Curr Top Microbiol Immunol 2006, 310:61-80.
36. Michaelis M., Köhler N., Reinisch A., et al. Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid. Biochem Pharmacol 2004, 68:531-538.
37. Takahashi R., Kano Y., Yamazaki Y., et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009, 182:8071-8079.
38. Joly P., Janela B., Tetart F., et al. Poor benefit/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol 2012, 148:543-544.
39. Barbaud A. Résultats des tests cutanés dans l'exploration des toxidermies. Ann Dermatol Venereol 2009, 136:635-644.
40. Ushigome Y., Kano Y., Ishida T., et al. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol 2012.